Literature DB >> 20859298

No efficacy of processed Fabuless (Olibra) in suppressing appetite or food intake.

H J Smit1, E Keenan, E M R Kovacs, S A Wiseman, H P F Peters, D J Mela, P J Rogers.   

Abstract

BACKGROUND/
OBJECTIVES: To investigate the feasibility of Fabuless (previously called Olibra and Reducal) as a food ingredient for food intake and appetite reduction, by assessing the effects of food processing on efficacy. SUBJECTS/
METHODS: In total, 24 healthy volunteers (16 female, 8 male; age: 18-43 years; body mass index: 18-37 kg/m(2)) took part in a randomized, placebo-controlled, double-blinded, cross-over trial. Yoghurt-based meal replacement drinks (containing processed or unprocessed Fabuless, or a control fat) were followed by an ad libitum lunch and evening meal (dinner). Key outcome measures were energy intake and self-reported appetite ratings.
RESULTS: Compared with control, only unprocessed Fabuless reduced subsequent energy intake, although only during dinner (P < 0.01; control, processed and unprocessed: 4.3, 3.9 and 4.2 MJ, respectively) and not during lunch (3.6, 3.7 and 3.6 MJ). Self-reported appetite scores did not differ between treatments.
CONCLUSIONS: Although modest effects of unprocessed Fabuless were seen on food intake, but not on appetite, the ingredient was not robust to common food-manufacturing processes (thermal and shear processing). Claims on reduced food intake and appetite relating to this ingredient in food products are, therefore, only valid if functionality has been demonstrated after all relevant processing and storage steps.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20859298     DOI: 10.1038/ejcn.2010.187

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  6 in total

Review 1.  Reduced-fat foods: the complex science of developing diet-based strategies for tackling overweight and obesity.

Authors:  David J McClements
Journal:  Adv Nutr       Date:  2015-05-15       Impact factor: 8.701

Review 2.  Efficacy of Olibra: a 12-week randomized controlled trial and a review of earlier studies.

Authors:  Candida J Rebello; Corby K Martin; William D Johnson; Carol E O'Neil; Frank L Greenway
Journal:  J Diabetes Sci Technol       Date:  2012-05-01

3.  An analysis of the "Effect of Olibra: a 12-week randomized control trial and a review of earlier studies".

Authors:  Martina Heer
Journal:  J Diabetes Sci Technol       Date:  2012-05-01

4.  Postprandial effects on plasma lipids and satiety hormones from intake of liposomes made from fractionated oat oil: two randomized crossover studies.

Authors:  Lena Ohlsson; Anna Rosenquist; Jens F Rehfeld; Magnus Härröd
Journal:  Food Nutr Res       Date:  2014-10-06       Impact factor: 3.894

Review 5.  The scale of the evidence base on the health effects of conventional yogurt consumption: findings of a scoping review.

Authors:  Julie M Glanville; Sam Brown; Raanan Shamir; Hania Szajewska; Jacqualyn F Eales
Journal:  Front Pharmacol       Date:  2015-10-30       Impact factor: 5.810

6.  The Effect of an Encapsulated Nutrient Mixture on Food Intake and Satiety: A Double-Blind Randomized Cross-Over Proof of Concept Study.

Authors:  Annick M E Alleleyn; Mark van Avesaat; Dina Ripken; Sinéad B Bleiel; Daniel Keszthelyi; Ellen Wilms; Freddy J Troost; Henk F J Hendriks; Adrian A M Masclee
Journal:  Nutrients       Date:  2018-11-17       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.